Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Patients and data tracking

- PMLiVE

Novartis gets OK for panobinostat in myeloma

First HDAC to receive positive FDA review

Eli Lilly HQ

Lilly delays filing of Lantus rival on safety concerns

Concerns over changes in liver fat detected in phase III trials

- PMLiVE

Google-backed genetic testing kit gains FDA approval

23andMe’s DNA test can alert consumers to their risks of certain diseases

- PMLiVE

Google-backed genetic testing kit gains FDA approval

23andMe’s DNA test can alert consumers to their risks of certain diseases

France flag

French pharma growth restricted by generics

New analysis finds country’s market value will grow only modestly in the coming years

- PMLiVE

Novo Nordisk’s oral GLP-1 analogue looks set for phase III

Semaglutide said to be one of the firm’s most promising prospects

- PMLiVE

Valeant swoops on Salix with $10bn takeover deal

Firm will also absorb Salix’s $4.6bn debt, adding to its existing $15bn

- PMLiVE

Werner Baumann to replace Brandicourt at Bayer

Will assume the role of chairman after the former boss jumped ship to Sanofi

- PMLiVE

Kymab names Anne Hyland as chief financial officer

Hyland joins from BBI Diagnostics

EU flag

Europe gains access to first stem cell drug

Chiesi's Holoclar has been given the green light for a rare eye condition

- PMLiVE

Communicating value

The global recession has changed the way the industry needs to market its medicines

- PMLiVE

Celgene gets first-line myeloma approval for Revlimid

Approved in the EU and US for newly-diagnosed patients

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links